| 000 | 01508 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250516040835.0 | ||
| 264 | 0 | _c20120308 | |
| 008 | 201203s 0 0 eng d | ||
| 022 | _a1432-0428 | ||
| 024 | 7 |
_a10.1007/s00125-011-2190-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSuissa, S | |
| 245 | 0 | 0 |
_aLong-term effects of insulin glargine on the risk of breast cancer. _h[electronic resource] |
| 260 |
_bDiabetologia _cSep 2011 |
||
| 300 |
_a2254-62 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBreast Neoplasms _xepidemiology |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xdrug therapy |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xadverse effects |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 | _aInsulin Glargine |
| 650 | 0 | 4 |
_aInsulin, Long-Acting _xadverse effects |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aProportional Hazards Models |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aTime |
| 650 | 0 | 4 | _aUnited Kingdom |
| 700 | 1 | _aAzoulay, L | |
| 700 | 1 | _aDell'Aniello, S | |
| 700 | 1 | _aEvans, M | |
| 700 | 1 | _aVora, J | |
| 700 | 1 | _aPollak, M | |
| 773 | 0 |
_tDiabetologia _gvol. 54 _gno. 9 _gp. 2254-62 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00125-011-2190-9 _zAvailable from publisher's website |
| 999 |
_c20875307 _d20875307 |
||